Functional Neuroimaging Biomarkers in Migraine: Diagnostic, Prognostic and Therapeutic Implications

Author(s): Antonio Russo, Marcello Silvestro, Alessandro Tessitore, Gioacchino Tedeschi*

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 34 , 2019

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Abstract:

Background: In current migraine clinical practice, conventional neuroimaging examinations are often sought to exclude possible causes of secondary headaches or migraineassociated disorders. Contrariwise, although advanced Magnetic Resonance Imaging (MRI) has improved tremendously our understanding of human brain processes in migraine patients, to the state of the art they have not superseded the conventional neuroimaging techniques in the migraine clinical setting.

Methods: A comprehensive review was conducted of PubMed citations by entering the keyword “marker” and/or “biomarker” combined with “migraine” and/or “headache”. Other keywords included “imaging” or “neuroimaging”, “structural” or “functional”. The only restriction was English-language publication. The abstracts of all articles meeting these criteria were reviewed, and the full text was retrieved and examined for relevant references.

Results: Several authors tried to identify imaging biomarkers able to identify different migraine phenotypes or, even better, to follow-up the same migraine patients during the course of the disease, to predict the evolution into more severe phenotypes and, finally, the response to specific treatment.

Conclusion: The identification of diagnostic, prognostic and therapeutic advanced neuroimaging biomarkers in the migraine clinical setting, in order to approach to patients in a more and more rational and “tailored” way, is extremely intriguing and futuristic. Unfortunately, reliable and robust neuroimaging biomarkers are still lacking for migraine, probably due to both not completely understood pathogenesis and clinical and neuroimaging heterogeneity. Although further longitudinal advanced neuroimaging studies, aimed to identify effective neuroimaging biomarkers, are needed, this review aims to collect the main and most recent works on this topic.

Keywords: Migraine, biomarkers, fMRI, diagnosis, prognosis, therapy.

[1]
Noseda, R.; Burstein, R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain, 2013, 154(Suppl. 1), S44-S53.
[http://dx.doi.org/10.1016/j.pain.2013.07.021] [PMID: 23891892]
[2]
Aguggia, M.; Saracco, M.G.; Cavallini, M.; Bussone, G.; Cortelli, P. Sensitization and pain. Neurol. Sci., 2013, 34(Suppl. 1), S37-S40.
[http://dx.doi.org/10.1007/s10072-013-1382-0] [PMID: 23695043]
[3]
Pietrobon, D.; Moskowitz, M.A. Pathophysiology of migraine. Annu. Rev. Physiol., 2013, 75, 365-391.
[http://dx.doi.org/10.1146/annurev-physiol-030212-183717] [PMID: 23190076]
[4]
Silberstein, S.D. Migraine. Lancet, 2004, 363(9406), 381-391.
[http://dx.doi.org/10.1016/S0140-6736(04)15440-8] [PMID: 15070571]
[5]
Burstein, R.; Yarnitsky, D.; Goor-Aryeh, I.; Ransil, B.J.; Bajwa, Z.H. An association between migraine and cutaneous allodynia. Ann. Neurol., 2000, 47(5), 614-624.
[http://dx.doi.org/10.1002/1531-8249(200005)47:5<614:AID-ANA9>3.0.CO;2-N] [PMID: 10805332]
[6]
Loder, E.; Burch, R.; Rizzoli, P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache, 2012, 52(6), 930-945.
[http://dx.doi.org/10.1111/j.1526-4610.2012.02185.x] [PMID: 22671714]
[7]
Sandrini, G.; Friberg, L.; Jänig, W.; Jensen, R.; Russell, D.; Sanchez del Rìo, M.; Sand, T.; Schoenen, J.; Buchem, M.; van Dijk, J.G. Neurophysiological tests and neuroimaging procedures in non-acute headache: guidelines and recommendations. Eur. J. Neurol., 2004, 11(4), 217-224.
[http://dx.doi.org/10.1111/j.1468-1331.2003.00785.x] [PMID: 15061822]
[8]
Lakhan, S.E.; Avramut, M.; Tepper, S.J. Structural and functional neuroimaging in migraine: insights from 3 decades of research. Headache, 2013, 53(1), 46-66.
[http://dx.doi.org/10.1111/j.1526-4610.2012.02274.x] [PMID: 23094683]
[9]
Prescott, J.W. Quantitative imaging biomarkers: the application of advanced image processing and analysis to clinical and preclinical decision making. J. Digit. Imaging, 2013, 26(1), 97-108.
[http://dx.doi.org/10.1007/s10278-012-9465-7] [PMID: 22415112]
[10]
Symms, M.; Jäger, H.R.; Schmierer, K.; Yousry, T.A. A review of structural magnetic resonance neuroimaging. J. Neurol. Neurosurg. Psychiatry, 2004, 75(9), 1235-1244.
[http://dx.doi.org/10.1136/jnnp.2003.032714] [PMID: 15314108]
[11]
Thompson. Electrical Units of Measurement. Popular Lectures, 1883 May 3, 1, 73.
[12]
Vasan, R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation, 2006, 113(19), 2335-2362.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.104.482570] [PMID: 16702488]
[13]
Phillip Law, W.; Miles, K.A. Incorporating prognostic imaging biomarkers into clinical practice. Cancer Imaging, 2013, 13(3), 332-341.
[http://dx.doi.org/10.1102/1470-7330.2013.9003] [PMID: 24060808]
[14]
Biomarkers Definitions Working Group.Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 2001, 69(3), 89-95.
[http://dx.doi.org/10.1067/mcp.2001.113989] [PMID: 11240971]
[15]
Smith, J.J.; Sorensen, A.G.; Thrall, J.H. Biomarkers in imaging: realizing radiology’s future. Radiology, 2003, 227(3), 633-638.
[http://dx.doi.org/10.1148/radiol.2273020518] [PMID: 12663828]
[16]
Clarke, L.P.; Sriram, R.D.; Schilling, L.B. Imaging as a Biomarker: Standards for change measurements in therapy workshop summary. Acad. Radiol., 2008, 15(4), 501-530.
[http://dx.doi.org/10.1016/j.acra.2007.10.021] [PMID: 18389935]
[17]
Fleming, J.O.; Carlsson, C.M. Biomarkers for neurology: Guides and lines. Neurology, 2014, 83(13), 1130-1131.
[http://dx.doi.org/10.1212/WNL.0000000000000825] [PMID: 25150288]
[18]
Russo, A.; Silvestro, M.; Tedeschi, G.; Tessitore, A. Physiopathology of migraine: what have we learned from functional imaging? Curr. Neurol. Neurosci. Rep., 2017, 17(12), 95.
[http://dx.doi.org/10.1007/s11910-017-0803-5] [PMID: 29063211]
[19]
Pietrobon, D.; Moskowitz, M.A. Pathophysiology of migraine. Annu. Rev. Physiol., 2013, 75, 365-391.
[http://dx.doi.org/10.1146/annurev-physiol-030212-183717] [PMID: 23190076]
[20]
Olesen, J.; Burstein, R.; Ashina, M.; Tfelt-Hansen, P. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol., 2009, 8(7), 679-690.
[http://dx.doi.org/10.1016/S1474-4422(09)70090-0] [PMID: 19539239]
[21]
Noseda, R.; Jakubowski, M.; Kainz, V.; Borsook, D.; Burstein, R. Cortical projections of functionally identified thalamic trigeminovascular neurons: implications for migraine headache and its associated symptoms. J. Neurosci., 2011, 31(40), 14204-14217.
[http://dx.doi.org/10.1523/JNEUROSCI.3285-11.2011] [PMID: 21976505]
[22]
Lauritzen, M. Pathophysiology of the migraine aura. The spreading depression theory. Brain, 1994, 117(Pt 1), 199-210.
[http://dx.doi.org/10.1093/brain/117.1.199] [PMID: 7908596]
[23]
Matharu, M.S.; Good, C.D.; May, A.; Bahra, A.; Goadsby, P.J. No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur. J. Neurol., 2003, 10(1), 53-57.
[http://dx.doi.org/10.1046/j.1468-1331.2003.00510.x] [PMID: 12534993]
[24]
Rocca, M.A.; Ceccarelli, A.; Falini, A.; Colombo, B.; Tortorella, P.; Bernasconi, L.; Comi, G.; Scotti, G.; Filippi, M. Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke, 2006, 37(7), 1765-1770.
[http://dx.doi.org/10.1161/01.STR.0000226589.00599.4d] [PMID: 16728687]
[25]
Jin, C.; Yuan, K.; Zhao, L.; Zhao, L.; Yu, D.; von Deneen, K.M.; Zhang, M.; Qin, W.; Sun, W.; Tian, J. Structural and functional abnormalities in migraine patients without aura. NMR Biomed., 2013, 26(1), 58-64.
[http://dx.doi.org/10.1002/nbm.2819] [PMID: 22674568]
[26]
Bashir, A.; Lipton, R.B.; Ashina, S.; Ashina, M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology, 2013, 81(14), 1260-1268.
[http://dx.doi.org/10.1212/WNL.0b013e3182a6cb32] [PMID: 23986301]
[27]
Schmidt-Wilcke, T.; Gänssbauer, S.; Neuner, T.; Bogdahn, U.; May, A. Subtle grey matter changes between migraine patients and healthy controls. Cephalalgia, 2008, 28(1), 1-4.
[http://dx.doi.org/10.1111/j.1468-2982.2007.01428.x] [PMID: 17986275]
[28]
Schmitz, N.; Admiraal-Behloul, F.; Arkink, E.B.; Kruit, M.C.; Schoonman, G.G.; Ferrari, M.D.; van Buchem, M.A. Attack frequency and disease duration as indicators for brain damage in migraine. Headache, 2008, 48(7), 1044-1055.
[http://dx.doi.org/10.1111/j.1526-4610.2008.01133.x] [PMID: 18479421]
[29]
Schmitz, N.; Arkink, E.B.; Mulder, M.; Rubia, K.; Admiraal-Behloul, F.; Schoonman, G.G.; Kruit, M.C.; Ferrari, M.D.; van Buchem, M.A. Frontal lobe structure and executive function in migraine patients. Neurosci. Lett., 2008, 440(2), 92-96.
[http://dx.doi.org/10.1016/j.neulet.2008.05.033] [PMID: 18556120]
[30]
Valfrè, W.; Rainero, I.; Bergui, M.; Pinessi, L. Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache, 2008, 48(1), 109-117.
[http://dx.doi.org/10.1111/j.1526-4610.2007.00723.x] [PMID: 18184293]
[31]
Kim, J.H.; Suh, S-I.; Seol, H.Y.; Oh, K.; Seo, W.K.; Yu, S.W.; Park, K.W.; Koh, S.B. Regional grey matter changes in patients with migraine: a voxel-based morphometry study. Cephalalgia, 2008, 28(6), 598-604.
[http://dx.doi.org/10.1111/j.1468-2982.2008.01550.x] [PMID: 18422725]
[32]
Ashburner, J.; Friston, K.J. Voxel-based morphometry--the methods. Neuroimage, 2000, 11(6 Pt 1), 805-821.
[http://dx.doi.org/10.1006/nimg.2000.0582] [PMID: 10860804]
[33]
Granziera, C.; DaSilva, A.F.M.; Snyder, J.; Tuch, D.S.; Hadjikhani, N. Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med., 2006, 3(10)e402
[http://dx.doi.org/10.1371/journal.pmed.0030402] [PMID: 17048979]
[34]
DaSilva, A.F.M.; Granziera, C.; Snyder, J.; Hadjikhani, N. Thickening in the somatosensory cortex of patients with migraine. Neurology, 2007, 69(21), 1990-1995.
[http://dx.doi.org/10.1212/01.wnl.0000291618.32247.2d] [PMID: 18025393]
[35]
Datta, R.; Detre, J.A.; Aguirre, G.K.; Cucchiara, B. Absence of changes in cortical thickness in patients with migraine. Cephalalgia, 2011, 31(14), 1452-1458.
[http://dx.doi.org/10.1177/0333102411421025] [PMID: 21911412]
[36]
Messina, R.; Rocca, M.A.; Colombo, B.; Valsasina, P.; Horsfield, M.A.; Copetti, M.; Falini, A.; Comi, G.; Filippi, M. Cortical abnormalities in patients with migraine: a surface-based analysis. Radiology, 2013, 268(1), 170-180.
[http://dx.doi.org/10.1148/radiol.13122004] [PMID: 23533286]
[37]
Maleki, N.; Becerra, L.; Brawn, J.; Bigal, M.; Burstein, R.; Borsook, D. Concurrent functional and structural cortical alterations in migraine. Cephalalgia, 2012, 32(8), 607-620.
[http://dx.doi.org/10.1177/0333102412445622] [PMID: 22623760]
[38]
Hougaard, A. Investigations of functional and structural changes in migraine with aura by magnetic resonance imaging. Dan. Med. J., 2015, 62(8), B5129.
[PMID: 26239598]
[39]
Maleki, N.; Linnman, C.; Brawn, J.; Burstein, R.; Becerra, L.; Borsook, D. Her versus his migraine: multiple sex differences in brain function and structure. Brain, 2012, 135(Pt 8), 2546-2559.
[http://dx.doi.org/10.1093/brain/aws175] [PMID: 22843414]
[40]
Magon, S.; May, A.; Stankewitz, A.; Goadsby, P.J.; Schankin, C.; Ashina, M.; Amin, F.M.; Seifert, C.L.; Mallar, C.M.; Müller, J.; Sprenger, T. Cortical abnormalities in episodic migraine: A multi-center 3T MRI study. Cephalalgia, 2019, 39(5), 665-673.
[http://dx.doi.org/10.1177/0333102418795163] [PMID: 30525946]
[41]
Schwedt, T.J.; Chong, C.D.; Wu, T.; Gaw, N.; Fu, Y.; Li, J. Accurate classification of chronic migraine via brain magnetic resonance imaging. Headache, 2015, 55(6), 762-777.
[http://dx.doi.org/10.1111/head.12584] [PMID: 26084235]
[42]
Porreca, F.; Ossipov, M.H.; Gebhart, G.F. Chronic pain and medullary descending facilitation. Trends Neurosci., 2002, 25(6), 319-325.
[http://dx.doi.org/10.1016/S0166-2236(02)02157-4] [PMID: 12086751]
[43]
Weiller, C.; May, A.; Limmroth, V.; Jüptner, M.; Kaube, H.; Schayck, R.V.; Coenen, H.H.; Diener, H.C. Brain stem activation in spontaneous human migraine attacks. Nat. Med., 1995, 1(7), 658-660.
[http://dx.doi.org/10.1038/nm0795-658] [PMID: 7585147]
[44]
Welch, K.M.; Nagesh, V.; Aurora, S.K.; Gelman, N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache, 2001, 41(7), 629-637.
[http://dx.doi.org/10.1046/j.1526-4610.2001.041007629.x] [PMID: 11554950]
[45]
Chen, Z.; Chen, X.; Liu, M.; Liu, S.; Ma, L.; Yu, S. Volume expansion of periaqueductal gray in episodic migraine: a pilot MRI structural imaging study. J. Headache Pain, 2017, 18(1), 83.
[http://dx.doi.org/10.1186/s10194-017-0797-z] [PMID: 28808987]
[46]
Rocca, M.A.; Messina, R.; Colombo, B.; Falini, A.; Comi, G.; Filippi, M. Structural brain MRI abnormalities in pediatric patients with migraine. J. Neurol., 2014, 261(2), 350-357.
[http://dx.doi.org/10.1007/s00415-013-7201-y] [PMID: 24305994]
[47]
Schwedt, T.J.; Chiang, C.C.; Chong, C.D.; Dodick, D.W. Functional MRI of migraine. Lancet Neurol., 2015, 14(1), 81-91.
[http://dx.doi.org/10.1016/S1474-4422(14)70193-0] [PMID: 25496899]
[48]
Jia, Z.; Tang, W.; Zhao, D.; Yu, S. Disrupted functional connectivity between the periaqueductal gray and other brain regions in a rat model of recurrent headache. Sci. Rep., 2017, 7(1), 3960.
[http://dx.doi.org/10.1038/s41598-017-04060-6] [PMID: 28638117]
[49]
Sprenger, T.; Borsook, D. Migraine changes the brain: neuroimaging makes its mark. Curr. Opin. Neurol., 2012, 25(3), 252-262.
[http://dx.doi.org/10.1097/WCO.0b013e3283532ca3] [PMID: 22487570]
[50]
Russo, A.; Tessitore, A.; Giordano, A.; Corbo, D.; Marcuccio, L.; De Stefano, M.; Salemi, F.; Conforti, R.; Esposito, F.; Tedeschi, G. Executive resting-state network connectivity in migraine without aura. Cephalalgia, 2012, 32(14), 1041-1048.
[http://dx.doi.org/10.1177/0333102412457089] [PMID: 22908362]
[51]
Schwedt, T.J.; Si, B.; Li, J.; Wu, T.; Chong, C.D. Migraine subclassification via a data-driven automated approach using multimodality factor mixture modeling of brain structure measurements. Headache, 2017, 57(7), 1051-1064.
[http://dx.doi.org/10.1111/head.13121] [PMID: 28627714]
[52]
Russo, A.; Tessitore, A.; Esposito, F.; Di Nardo, F.; Silvestro, M.; Trojsi, F.; De Micco, R.; Marcuccio, L.; Schoenen, J.; Tedeschi, G. Functional changes of the perigenual part of the anterior cingulate cortex after external trigeminal neurostimulation in migraine patients. Front. Neurol., 2017, 8, 282.
[http://dx.doi.org/10.3389/fneur.2017.00282] [PMID: 28663737]
[53]
Neuhauser, H.K.; Radtke, A.; von Brevern, M.; Feldmann, M.; Lezius, F.; Ziese, T.; Lempert, T. Migrainous vertigo: prevalence and impact on quality of life. Neurology, 2006, 67(6), 1028-1033.
[http://dx.doi.org/10.1212/01.wnl.0000237539.09942.06] [PMID: 17000973]
[54]
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders , 3rd edition (beta version). Cephalalgia. 2013, 33(9), 629-808.
[http://dx.doi.org/10.1177/0333102413485658] [PMID: 23771276]
[55]
Russo, A.; Marcelli, V.; Esposito, F.; Corvino, V.; Marcuccio, L.; Giannone, A.; Conforti, R.; Marciano, E.; Tedeschi, G.; Tessitore, A. Abnormal thalamic function in patients with vestibular migraine. Neurology, 2014, 82(23), 2120-2126.
[http://dx.doi.org/10.1212/WNL.0000000000000496] [PMID: 24814847]
[56]
Faria, V.; Erpelding, N.; Lebel, A.; Johnson, A.; Wolff, R.; Fair, D.; Burstein, R.; Becerra, L.; Borsook, D. The migraine brain in transition: girls vs boys. Pain, 2015, 156(11), 2212-2221.
[http://dx.doi.org/10.1097/j.pain.0000000000000292] [PMID: 26172552]
[57]
Androulakis, X.M.; Krebs, K.; Peterlin, B.L.; Zhang, T.; Maleki, N.; Sen, S.; Rorden, C.; Herath, P. Modulation of intrinsic resting-state fMRI networks in women with chronic migraine. Neurology, 2017, 89(2), 163-169.
[http://dx.doi.org/10.1212/WNL.0000000000004089] [PMID: 28615426]
[58]
Vincent, M.B.; Hadjikhani, N. Migraine aura and related phenomena: beyond scotomata and scintillations. Cephalalgia, 2007, 27(12), 1368-1377.
[http://dx.doi.org/10.1111/j.1468-2982.2007.01388.x] [PMID: 17944958]
[59]
Main, A.; Dowson, A.; Gross, M. Photophobia and phonophobia in migraineurs between attacks. Headache, 1997, 37(8), 492-495.
[http://dx.doi.org/10.1046/j.1526-4610.1997.3708492.x] [PMID: 9329231]
[60]
Vanagaite, J.; Pareja, J.A.; Støren, O.; White, L.R.; Sand, T.; Stovner, L.J. Light-induced discomfort and pain in migraine. Cephalalgia, 1997, 17(7), 733-741.
[http://dx.doi.org/10.1046/j.1468-2982.1997.1707733.x] [PMID: 9399002]
[61]
Martín, H.; Sánchez del Río, M.; de Silanes, C.L.; Álvarez-Linera, J.; Hernández, J.A.; Pareja, J.A. Photoreactivity of the occipital cortex measured by functional magnetic resonance imaging-blood oxygenation level dependent in migraine patients and healthy volunteers: pathophysiological implications. Headache, 2011, 51(10), 1520-1528.
[http://dx.doi.org/10.1111/j.1526-4610.2011.02013.x] [PMID: 22082422]
[62]
Datta, R.; Aguirre, G.K.; Hu, S.; Detre, J.A.; Cucchiara, B. Interictal cortical hyperresponsiveness in migraine is directly related to the presence of aura. Cephalalgia, 2013, 33(6), 365-374.
[http://dx.doi.org/10.1177/0333102412474503] [PMID: 23359872]
[63]
Tedeschi, G.; Russo, A.; Conte, F.; Corbo, D.; Caiazzo, G.; Giordano, A.; Conforti, R.; Esposito, F.; Tessitore, A. Increased interictal visual network connectivity in patients with migraine with aura. Cephalalgia, 2016, 36(2), 139-147.
[http://dx.doi.org/10.1177/0333102415584360] [PMID: 25926619]
[64]
Huang, J.; Cao, Y. Functional MRI as a biomarker for evaluation and prediction of effectiveness of migraine prophylaxis. Biomarkers Med., 2012, 6(4), 517-527.
[http://dx.doi.org/10.2217/bmm.12.35] [PMID: 22917153]
[65]
Wilkins, A. Visual Stress; Oxford University Press: UK, 1995.
[http://dx.doi.org/10.1093/acprof:oso/9780198521747.001.0001]
[66]
Marcus, D.A.; Soso, M.J. Migraine and stripe-induced visual discomfort. Arch. Neurol., 1989, 46(10), 1129-1132.
[http://dx.doi.org/10.1001/archneur.1989.00520460125024] [PMID: 2803073]
[67]
Wilkins, A.; Nimmo-Smith, I.; Tait, A.; McManus, C.; Della Sala, S.; Tilley, A.; Arnold, K.; Barrie, M.; Scott, S. A neurological basis for visual discomfort. Brain, 1984, 107(Pt 4), 989-1017.
[http://dx.doi.org/10.1093/brain/107.4.989] [PMID: 6509314]
[68]
Huang, J.; Cooper, T.G.; Satana, B.; Kaufman, D.I.; Cao, Y. Visual distortion provoked by a stimulus in migraine associated with hyperneuronal activity. Headache, 2003, 43(6), 664-671.
[http://dx.doi.org/10.1046/j.1526-4610.2003.03110.x] [PMID: 12786927]
[69]
Huang, J.; Zong, X.; Wilkins, A.; Jenkins, B.; Bozoki, A.; Cao, Y. fMRI evidence that precision ophthalmic tints reduce cortical hyperactivation in migraine. Cephalalgia, 2011, 31(8), 925-936.
[http://dx.doi.org/10.1177/0333102411409076] [PMID: 21622479]
[70]
Rossato, G.; Adami, A.; Thijs, V.N.; Cerini, R.; Pozzi-Mucelli, R.; Mazzucco, S.; Anzola, G.P.; Del Sette, M.; Dinia, L.; Meneghetti, G.; Zanferrari, C. Cerebral distribution of white matter lesions in migraine with aura patients. Cephalalgia, 2010, 30(7), 855-859.
[http://dx.doi.org/10.1177/0333102409355660] [PMID: 20647177]
[71]
Ziegler, D.K.; Batnitzky, S.; Barter, R.; McMillan, J.H. Magnetic resonance image abnormality in migraine with aura. Cephalalgia, 1991, 11(3), 147-150.
[http://dx.doi.org/10.1046/j.1468-2982.1991.1103147.x] [PMID: 1889071]
[72]
Kruit, M.C.; van Buchem, M.A.; Hofman, P.A.M.; Bakkers, J.T.; Terwindt, G.M.; Ferrari, M.D.; Launer, L.J. Migraine as a risk factor for subclinical brain lesions. JAMA, 2004, 291(4), 427-434.
[http://dx.doi.org/10.1001/jama.291.4.427] [PMID: 14747499]
[73]
Launer, L.J. Epidemiology of white matter lesions. Top. Magn. Reson. Imaging, 2004, 15(6), 365-367.
[http://dx.doi.org/10.1097/01.rmr.0000168216.98338.8d] [PMID: 16041288]
[74]
Debette, S.; Markus, H.S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 2010, 341, c3666.
[http://dx.doi.org/10.1136/bmj.c3666] [PMID: 20660506]
[75]
Schürks, M.; Rist, P.M.; Shapiro, R.E.; Kurth, T. Migraine and mortality: a systematic review and meta-analysis. Cephalalgia, 2011, 31(12), 1301-1314.
[http://dx.doi.org/10.1177/0333102411415879] [PMID: 21803936]
[76]
Trauninger, A.; Leél-Ossy, E.; Kamson, D.O.; Pótó, L.; Aradi, M.; F., Kövér F.; Imre, M.; Komáromy, H.; Erdélyi-Botor, S.; Patzkó, Á.; Zoltán, P. Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients. J. Headache Pain, 2011, 12(1), 97-103.
[77]
Kurth, T.; Mohamed, S.; Maillard, P.; Zhu, Y.C.; Chabriat, H.; Mazoyer, B.; Bousser, M.G.; Dufouil, C.; Tzourio, C. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ, 2011, 342, c7357.
[http://dx.doi.org/10.1136/bmj.c7357] [PMID: 21245119]
[78]
Sándor, P.S.; Mascia, A.; Seidel, L.; de Pasqua, V.; Schoenen, J. Subclinical cerebellar impairment in the common types of migraine: a three-dimensional analysis of reaching movements. Ann. Neurol., 2001, 49(5), 668-672.
[http://dx.doi.org/10.1002/ana.1019] [PMID: 11357959]
[79]
Aurora, S.K.; Brin, M.F. Chronic migraine: an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies. Headache, 2017, 57(1), 109-125.
[http://dx.doi.org/10.1111/head.12999] [PMID: 27910097]
[80]
Bigal, M.E.; Lipton, R.B. Concepts and mechanisms of migraine chronification. Headache, 2008, 48(1), 7-15.
[http://dx.doi.org/10.1111/j.1526-4610.2007.00969.x] [PMID: 18184280]
[81]
Bigal, M.E.; Rapoport, A.M.; Sheftell, F.D.; Tepper, S.J.; Lipton, R.B. Chronic migraine is an earlier stage of transformed migraine in adults. Neurology, 2005, 65(10), 1556-1561.
[http://dx.doi.org/10.1212/01.wnl.0000184477.11569.17] [PMID: 16301481]
[82]
Headache Classification Committee.Olesen, J.; Bousser, M.G.; Diener, H.C.; Dodick, D.; First, M.; Goadsby, P.J.; Göbel, H.; Lainez, M.J.; Lance, J.W.; Lipton, RB.; Nappi, G.; Sakai, F.; Schoenen, J.; Silberstein, S.D.; Steiner, T.J. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia, 2006, 26(6), 742-746.
[http://dx.doi.org/ 10.1111/j.1468-2982.2006.01172.x] [PMID: 16686915]
[83]
Borsook, D.; Maleki, N.; Becerra, L.; McEwen, B. Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron, 2012, 73(2), 219-234.
[http://dx.doi.org/10.1016/j.neuron.2012.01.001] [PMID: 22284178]
[84]
Manack, A.N.; Buse, D.C.; Lipton, R.B. Chronic migraine: epidemiology and disease burden. Curr. Pain Headache Rep., 2011, 15(1), 70-78.
[http://dx.doi.org/10.1007/s11916-010-0157-z] [PMID: 21063918]
[85]
Lai, T.H.; Protsenko, E.; Cheng, Y.C.; Loggia, M.L.; Coppola, G.; Chen, W.T. Neural plasticity in common forms of chronic headaches. Neural Plast., 2015.2015205985
[http://dx.doi.org/10.1155/2015/205985] [PMID: 26366304]
[86]
Lovati, C.; Giani, L.; Mele, F.; Sinelli, A.; Tien, T.T.; Preziosa, G.; Mariani, C. Brain plasticity and migraine transformation: fMRI evidences. Expert Rev. Neurother., 2016, 16(12), 1413-1425.
[http://dx.doi.org/10.1080/14737175.2016.1208565] [PMID: 27388277]
[87]
Scher, A.I.; Midgette, L.A.; Lipton, R.B. Risk factors for headache chronification. Headache, 2008, 48(1), 16-25.
[http://dx.doi.org/10.1111/j.1526-4610.2007.00970.x] [PMID: 18184281]
[88]
Lovati, C.; D’Amico, D.; Bertora, P. Allodynia in migraine: frequent random association or unavoidable consequence? Expert Rev. Neurother., 2009, 9(3), 395-408.
[http://dx.doi.org/10.1586/14737175.9.3.395] [PMID: 19271948]
[89]
Dodick, D.; Silberstein, S. Central sensitization theory of migraine: clinical implications. Headache, 2006, 46(Suppl. 4), S182-S191.
[http://dx.doi.org/10.1111/j.1526-4610.2006.00602.x] [PMID: 17078850]
[90]
Louter, M.A.; Bosker, J.E.; van Oosterhout, W.P.; van Zwet, E.W.; Zitman, F.G.; Ferrari, M.D.; Terwindt, G.M. Cutaneous allodynia as a predictor of migraine chronification. Brain, 2013, 136(Pt 11), 3489-3496.
[http://dx.doi.org/10.1093/brain/awt251] [PMID: 24080152]
[91]
Russo, A.; Esposito, F.; Conte, F.; Fratello, M.; Caiazzo, G.; Marcuccio, L.; Giordano, A.; Tedeschi, G.; Tessitore, A. Functional interictal changes of pain processing in migraine with ictal cutaneous allodynia. Cephalalgia, 2017, 37(4), 305-314.
[http://dx.doi.org/10.1177/0333102416644969] [PMID: 27084886]
[92]
Moulton, E.A.; Burstein, R.; Tully, S.; Hargreaves, R.; Becerra, L.; Borsook, D. Interictal dysfunction of a brainstem descending modulatory center in migraine patients. PLoS One, 2008, 3(11)e3799
[http://dx.doi.org/10.1371/journal.pone.0003799] [PMID: 19030105]
[93]
Chong, C.D.; Plasencia, J.D.; Frakes, D.H.; Schwedt, T.J. Structural alterations of the brainstem in migraine. Neuroimage Clin., 2016, 13, 223-227.
[http://dx.doi.org/10.1016/j.nicl.2016.10.023] [PMID: 28003961]
[94]
Denuelle, M.; Fabre, N.; Payoux, P.; Chollet, F.; Geraud, G. Hypothalamic activation in spontaneous migraine attacks. Headache, 2007, 47(10), 1418-1426.
[http://dx.doi.org/ 10.1111/j.1526-4610.2007.00776.x] [PMID: 18052951]
[95]
Schulte, L.H.; Allers, A.; May, A. Hypothalamus as a mediator of chronic migraine: Evidence from high-resolution fMRI. Neurology, 2017, 88(21), 2011-2016.
[http://dx.doi.org/10.1212/WNL.0000000000003963] [PMID: 28446645]
[96]
Hubbard, C.S.; Becerra, L.; Smith, J.H.; DeLange, J.M.; Smith, R.M.; Black, D.F.; Welker, K.M.; Burstein, R.; Cutrer, F.M.; Borsook, D. Brain changes in responders vs. non-responders in chronic migraine: markers of disease reversal. Front. Hum. Neurosci., 2016, 10, 497.
[http://dx.doi.org/10.3389/fnhum.2016.00497] [PMID: 27766076]
[97]
Chong, C.D.; Starling, A.J.; Schwedt, T.J. Interictal photosensitivity associates with altered brain structure in patients with episodic migraine. Cephalalgia, 2016, 36(6), 526-533.
[http://dx.doi.org/10.1177/0333102415606080] [PMID: 26378082]
[98]
Liu, J.; Zhao, L.; Lei, F.; Zhang, Y.; Yuan, K.; Gong, Q.; Liang, F.; Tian, J. Disrupted resting-state functional connectivity and its changing trend in migraine suffers. Hum. Brain Mapp., 2015, 36(5), 1892-1907.
[http://dx.doi.org/10.1002/hbm.22744] [PMID: 25640857]
[99]
Olesen, J. International Classification of Headache Disorders, Second Edition (ICHD-2): current status and future revisions. Cephalalgia, 2006, 26(12), 1409-1410.
[http://dx.doi.org/10.1111/j.1468-2982.2006.01214.x] [PMID: 17116090]
[100]
Torta, D.M.; Costa, T.; Luda, E.; Barisone, M.G.; Palmisano, P.; Duca, S.; Geminiani, G.; Cauda, F. Nucleus accumbens functional connectivity discriminates medication-overuse headache. Neuroimage Clin., 2016, 11, 686-693.
[http://dx.doi.org/10.1016/j.nicl.2016.05.007] [PMID: 27330969]
[101]
Riederer, F.; Gantenbein, A.R.; Marti, M.; Luechinger, R.; Kollias, S.; Sándor, P.S. Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex. J. Neurosci., 2013, 33(39), 15343-15349.
[http://dx.doi.org/10.1523/JNEUROSCI.3804-12.2013] [PMID: 24068801]
[102]
Ferraro, S.; Grazzi, L.; Muffatti, R.; Nava, S.; Ghielmetti, F.; Bertolino, N.; Mandelli, M.L.; Visintin, E.; Bruzzone, M.G.; Nigri, A.; Epifani, F.; Bussone, G.; Chiapparini, L. In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas. Headache, 2012, 52(10), 1520-1534.
[http://dx.doi.org/10.1111/j.1526-4610.2012.02276.x] [PMID: 23094707]
[103]
Lai, T.H.; Chou, K.H.; Fuh, J.L.; Lee, P.L.; Kung, Y.C.; Lin, C.P.; Wang, S.J. Gray matter changes related to medication overuse in patients with chronic migraine. Cephalalgia, 2016, 36(14), 1324-1333.
[http://dx.doi.org/10.1177/0333102416630593] [PMID: 26853805]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 34
Year: 2019
Page: [6236 - 6252]
Pages: 17
DOI: 10.2174/0929867325666180406115427
Price: $65

Article Metrics

PDF: 40
HTML: 7